Skip to main content
Caplight Logo









Dr. SAM Germany GmbH

Dr. SAM Germany GmbH

Private
DusseldorfHealthcare & Life Scienceshttps://wf-3.drsam.de/

Last Round

VC Round

Aug 23, 2021

Company Overview

Dr. SAM Germany GmbH is a digital veterinary platform that provides online teleconsultations, AI-assisted health assessments, and veterinary-approved health products for pets.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

telemedicineveterinary consultationtele-veterinarypet healthvet telehealthonline vetdigital healthsubscription saasai triageveterinary advicepet care appai vetremote diagnosisd2c brandsvetflat

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dr. SAM Germany GmbH Comparables

Compare Dr. SAM Germany GmbH with similar companies based on industry and business-model similarity.

Dr. SAM Germany GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Petcare Solutions GmbH
93%
FirstVet
81%
Dutch
78%

Dr. SAM Germany GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 23, 2021
SeedMay 18, 2020

Key People

Founding team and executive leadership

Aurore Salmon Wirjawan

Co CEO

Executive Team

Beat Seeliger

Deputy CTO

Executive Team

Dr. SAM Germany GmbH Investors

Notable investors and investment history

Dr. SAM Germany GmbH investors
InvestorRounds
Vega VenturesSeed
Tech Vision FondsVC Round
Mavericks FoundersSeed
Joyance PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2025

    Grew 27% QoQ from 15 to 19 employees.

  • May 18, 2020

    Seed round with participation from Joyance Partners and Caspar Health.

Dr. SAM Germany GmbH Filings

Explore SEC and related filing metadata, where available.

Dr. SAM Germany GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dr. SAM Germany GmbH's valuation, stock price, and market status.

Is Dr. SAM Germany GmbH a public or private company?

Dr. SAM Germany GmbH is a private company.

What is the current stock price of Dr. SAM Germany GmbH?

Dr. SAM Germany GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Dr. SAM Germany GmbH worth (valuation)?

Valuation information for Dr. SAM Germany GmbH is not publicly available.

Can I buy Dr. SAM Germany GmbH stock?

Dr. SAM Germany GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dr. SAM Germany GmbH's last funding round?

Dr. SAM Germany GmbH's most recent funding round was VC Round on August 23, 2021.

Who are the main investors in Dr. SAM Germany GmbH?

Key investors in Dr. SAM Germany GmbH include Tech Vision Fonds.

Will Dr. SAM Germany GmbH IPO soon?

No public IPO plans have been announced for Dr. SAM Germany GmbH.

How can I track Dr. SAM Germany GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dr. SAM Germany GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDusseldorf
Employee Range17
Year Founded2018
Last FundingAug 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?